WASHINGTON D.C. (WBAP/KLIF News) – A second at-home antiviral pill to treat COVID-19 is headed to the American marketplace. The U.S. Food and Drug Administration granted emergency use authorization for Merck’s drug molnupiravir on Thursday.. The drug is cleared for use in high-risk adults with mild to moderate COVID-19 symptoms. The pharmaceutical company said studies…… MORE